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Abstract: Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease, 
leading to death within an average of 2–3 years. A cure is yet to be found, and a single disease-
modifying treatment has had a modest effect in slowing disease progression. Specialized 
multidisciplinary ALS care has been shown to extend survival and improve patients’ quality of 
life, by providing coordinated interprofessional care that seeks to address the complex needs 
of this patient group. This review examines the nature of specialized multidisciplinary care 
in ALS and draws on a broad range of evidence that has shaped current practice. The authors 
explain how multidisciplinary ALS care is delivered. The existing models of care, the role of 
palliative care within multidisciplinary ALS care, and the costs of formal and informal care are 
examined. Critical issues of ALS care are then discussed in the context of the support rendered 
by multidisciplinary-based care. The authors situate the patient and family as key stakeholders 
and decision makers in the multidisciplinary care network. Finally, the current challenges to the 
delivery of coordinated interprofessional care in ALS are explored, and the future of coordinated 
interprofessional care for people with ALS and their family caregivers is considered. 
Keywords: quality of life, interdisciplinary, interprofessional, palliative care, care coordina-
tion, motor neuron disease
Introduction
Amyotrophic lateral sclerosis (ALS), also known as motor neuron disease (MND), is 
a progressive and terminal neurodegenerative disease. The lifetime risk of developing 
the condition is 1:400. On average, death results within 2–3 years from symptom 
onset.1,2 Characterized by heterogeneous patterns of deterioration, presenting symp-
toms range from falls, limb weakness, communication, and swallowing difficulties 
to changes in mood, cognition, and behavior.1,3,4 Up to 50% of people with ALS 
develop some degree of frontotemporal impairment.5,6 Patients may also be at risk 
of psychological problems such as depression and anxiety, linked to their disease 
experiences.4,7,8 No cure exists for ALS, and only a small number of treatments (eg, 
riluzole [pharmaceutical agent], non-invasive ventilation) delay death. Death usually 
results from respiratory failure. Care delivered and coordinated by multidisciplinary 
clinics (MDCs) specializing in ALS has been shown to extend survival and improve 
the quality of life for patients.9,10
To date, reviews of multidisciplinary (also known as interprofessional or inter-
disciplinary) ALS care have focused on symptom management and on the roles of 
health professionals in delivering care.11,12 However, such work does not illuminate 
the wider complexity of processes that underpin service delivery in multidisciplinary 
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ALS care. Challenges to delivering multidisciplinary ALS 
care include: less than seamless coordination and transition 
of care between health care professionals across different 
sectors; patients’ and family members’ evolving expectations 
of care;13,14 and the lack of support available to health care 
professionals to deliver evidence-based care to patients and 
their families.15 Importantly, the roles of the patient, carer, 
and ALS support associations within the multidisciplinary 
team have not always been considered. A greater understand-
ing of multidisciplinary care practices and of patients’ and 
families’ decision-making processes in ALS care can help 
generate more effective models of care.15
This review draws on a broad base of evidence pertaining 
to multidisciplinary ALS care, to help decipher how multi-
disciplinary care is best delivered to ALS patients and their 
family. First, multidisciplinary ALS care and the evidence 
that supports the effectiveness of multidisciplinary-based care 
in ALS are summarized and defined. Then, critical issues in 
ALS care and how MDCs are positioned to address them 
are considered. Finally, the challenges to the delivery of 
multidisciplinary ALS care and the benefits MDC care offers 
people and families living with ALS are outlined.
What is multidisciplinary care in ALS?
Multidisciplinary care in ALS encompasses the provision 
of care to the ALS patient and their family by a range of 
health care disciplines and support services. It is known that 
multidisciplinary care occurs when professionals who have 
different skills, knowledge, and experiences work together 
to achieve optimal care for patients and their families. Given 
the multitude of physical problems (eg, loss of mobility, 
respiratory failure, dysarthria, and dysphagia) and psycho-
social problems (eg, depression, loss, bereavement, and 
family distress) posed by ALS, patients and their families 
engage with a variety of health care disciplines (Table 1). 
To comprehensively address ALS patients’ broad range of 
needs, multidisciplinary care optimally includes medical 
practitioners in neurology, respiratory, gastroenterology, 
rehabilitation, and/or palliative care; allied health care profes-
sionals in physiotherapy, occupational therapy, speech and 
language pathology, nutrition and social work; and health 
professionals in specialist nursing, genetic counseling and 
psychology, including neuropsychology.10,16,17 Voluntary 
support services, mostly in the form of national and regional 
ALS/MND associations, also play an integral role in the 
Table 1 Multidisciplinary approaches to symptom management
Issue Treatment options Health care and support professionals involved
Disease progression Riluzole Neurologist/rehabilitation physician
Breathing difficulty Assisted ventilation Respiratory physician
Respiratory therapist
Nursing
Eating and drinking difficulties Gastrostomy Gastroenterologist
Dietitian
Speech pathologist
Nursing
Saliva management Medication Neurologist/general practitioner/palliative care team
Botox Neurologist
Mobility Mobility equipment Physiotherapist
Occupational therapist
ALS association
Cognitive, behavior, and mood issues Counseling and support for patient and family Neuropsychologist
Psychologist
Self-care Assistive equipment Occupational therapist
Nursing
ALS association
Communication Alternative communication devices Speech pathologist
Occupational therapist
ALS association
Grief and loss Counseling and support for patient and family Social worker
Psychologist 
ALS association
Palliative care team
Carer support Counseling and support for patient and family Social worker
ALS association
Palliative care team
Abbreviation: ALS, amyotrophic lateral sclerosis.
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delivery of care to patients and their families. In developed 
countries, the voluntary sector has been shown to coordinate 
care for ALS patients and supplement the care that patients 
and their families receive from health services.18–20
Although multidisciplinary care is not limited to specific 
care settings or indeed to specialist care, the term “multidisci-
plinary” in ALS has become synonymous with care provided 
by MDCs.21–23 Activation of inter-service communication 
across different care sectors by specialized ALS clinics 
has proven to be essential for the delivery of high-quality 
care in ALS.18,24 Linkage between specialized MDCs and 
community-based services, general practitioner (or family 
physician), and palliative care services is required, so that 
by the terminal phase of the disease, many ALS patients and 
caregivers have experienced multiple encounters with dif-
ferent health care professionals across different health care 
sectors. Effective delivery of multidisciplinary care in ALS 
requires seamless collaboration, coordination, and transi-
tion between numerous health care professionals within and 
between disciplines, across a range of health care services 
and sectors. 
Guidelines for the clinical management of ALS have been 
published in Europe, the UK, and the US.10,16,25 Health profes-
sional compliance with these guidelines has been assessed 
at specialized MDCs, to reveal reasonably high levels of 
implementation.26 However, patient adherence to health 
professionals’ recommendations can vary.27 Ideally, patients 
should be reviewed every 2–3 months at an MDC, with the 
MDC team maintaining regular contact with the patient and 
family between visits. Patients should be followed by the 
same neurologist who in turn should liaise closely with the 
patient’s primary care physician. Importantly, coordination of 
the patient’s care requires effective communication between 
the MDC team, the palliative care team, and community-
based services.16,26 
Standards in ALS care have been set by specialized ALS 
clinics.26,28 ALS MDC-based care in the Netherlands has 
resulted in improved quality of life for patients and greater 
provision of aids and equipment to patients.29 Specialized 
ALS MDCs in Italy have increased survival and reduced 
hospital admissions and length of hospital stay for patients.30 
Traynor et al31 found improved survival of 7.5 months, with 
1-year mortality being reduced by 30% for patients attend-
ing a national ALS clinic in Ireland. Extended survival 
rates have also been identified in a more recent Irish study 
focused on the effects of an ALS MDC on patient survival.32 
The aforementioned studies reported better outcomes when 
compared to care that was not multidisciplinary; although, 
as comparison groups are not always well matched, gen-
eralized comparison is difficult. Zoccolella et al33 found 
that MDC care did not improve survival when compared to 
general neurology care. However, respiratory and nutritional 
interventions were low for these groups, and the MDC did 
not link directly to community-based services or palliative 
care services.33 It is likely that survival in ALS is influenced 
by the complex decision-making processes that occur in 
the multidisciplinary setting, rather than by the effects of 
symptomatic interventions alone.32 
Models of multidisciplinary care in ALS
A coordinated, interprofessional approach to address the 
needs of ALS patients is represented in several models 
of care.21–24,34–36 These models share a patient-centered 
approach37 and recognize that patients and their family 
members are key stakeholders in care and have active roles 
in the decision-making process.38,39 Family caregivers are 
central to the care and support of people with ALS, and they 
too encounter multiple losses in their caring role. Caring 
for a person with ALS can be physically and emotionally 
demanding for family members,40–42 and family caregivers 
who feel unsupported by health care professionals can experi-
ence increased caregiver strain.41 Although family caregivers 
tend to have a pivotal role in the provision of informal care 
and support to the patient,43 ALS family caregivers’ needs 
can be overlooked by service providers.44,45 As for patients, 
family caregivers in ALS navigate the challenges posed by 
ALS and assume high levels of responsibility within the 
ALS care triad (the person with ALS, the family carer, and 
the health care provider).44,46
Multidisciplinary ALS care is dynamic and has the capac-
ity to adapt to different healthcare contexts. Multidisciplinary 
ALS care can be provided by publicly or privately funded 
organizations delivering neurology, rehabilitation, and pal-
liative care services, across primary, secondary, and tertiary 
care sectors. In many cases, patients and families work with 
clinicians from different multidisciplinary teams that form 
their broader ALS-specialized multidisciplinary service – a 
team within a team. For example, patients may engage with 
neurology and palliative care-based health professionals who 
interface at key points along the patient’s trajectory. Care in 
ALS is most effective when coordinated between specialized 
MDCs, the community-based sector (including primary care), 
and palliative care teams.16 Corr et al18 have shown that close 
liaison between a specialized ALS clinic, community-based 
services (eg, allied health care professionals, physicians, and 
homecare services), and the voluntary sector (ie, the local 
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ALS association) can render effective care for ALS patients. 
In addition, there are potential benefits of specialized nurse 
coordinators in a liaison role, particularly in the later stages 
of the disease.47 
Multidisciplinary care in ALS is appropriate throughout 
the disease course (ie, diagnostic, disability, pre-terminal, 
and terminal phases)24 and is rendered via rehabilitative and 
palliative approaches to care. “Rehabilitation” is understood 
in the context of interventions that can assist patients and 
their families to adapt to the physical and psychological 
challenges of living with ALS (ie, counseling, social support, 
alleviation of spasticity, provision of orthotics and appliances, 
and training in assistive technology), rather than regain the 
physical loss or remedy the cognitive change encountered by 
ALS patients.21,48,49 The term “palliative” infers an approach 
that seeks to alleviate physical, psychological, and existential 
distress.
The role of palliative care in 
multidisciplinary ALS care
Palliative care is essential for patients with ALS and their 
families to ensure their symptoms and issues are clearly 
identified and appropriately managed50 and to improve the 
quality of life for patients and their carers.14,51 In ALS, pal-
liative care is appropriate from the time of diagnosis,16,52 
especially as the extended duration between symptom onset 
and diagnosis means many patients are severely disabled by 
the time they are diagnosed. Members of the palliative care 
team, led by a specialist palliative care physician, may work 
in a multidisciplinary context within their own care setting 
(such as community or home-based palliative care, special-
ized inpatient and outpatient palliative care facilities). The 
palliative care team is part of the wider multidisciplinary care 
approach that traverses the different care sectors involved in 
delivering services to ALS patients and their families. 
However, few palliative care frameworks have been 
developed to guide active palliative care engagement in 
ALS.51 There may be issues within and between the acute 
care, rehabilitation, and palliative care teams involved, due 
to the differing attitudes and philosophies of patient care. It 
is important that there is awareness of and negotiation around 
these issues to enable well-coordinated care and seamless 
transition between services.53 Nonetheless, the palliative 
approach in ALS care can accommodate the evolving needs 
of the patient and their family2,51 (Figure 1). The palliative care 
needs of patients and their family can vary and fluctuate. The 
involvement of specialist teams may be episodic, occurring at 
times of change, crisis, or decision making – for example, at 
diagnosis, when discussing gastrostomy or ventilatory support, 
or when change in patient cognition or behavior occurs, which 
may impact on the timing or appropriateness of decisions at the 
end of life35,51 (Figure 2). Overall, optimal palliative manage-
ment of people with ALS and their family requires integrated 
MDC and palliative- and community-based intervention.54,55
What are the costs of formal and 
informal ALS care?
Costs associated with ALS care have been evaluated in a num-
ber of countries.56–62 MDC-based care has been  cost-effective 
Diagnosis – breaking the bad news
Psychological and spiritual support
Treatment of symptoms
Complex symptom management
(gastrostomy, ventilation)
End-of-life decision making
End-of-life care
Bereavement support
Figure 1 Development of a palliative approach in ALS.
Note: Reprinted from Lancet, 369(9578), Mitchell JD, Borasio GD, Amyotrophic 
lateral sclerosis, 2031–2041, Copyright (2007), with permission from Elsevier.2
Abbreviation: ALS, amyotrophic lateral sclerosis.
Specialist palliative care
Diagnosis Death
Neurology and medical specialties
Specialist palliative care
Diagnosis Death
Neurology and medical specialties
Specialist palliative care
Diagnosis
A
B
C
Death
Neurology and medical specialties
Trigger points
Figure 2 Involvement of palliative care in ALS and other neurological diseases.
Notes: (A) The traditional model of late involvement of specialist palliative services. 
(B) The model of early and increasing involvement of specialist palliative services. (C) 
The model of dynamic involvement of palliative services based on trigger 
points. Reproduced from Bede P, Hardiman O, O’Brannagain D. An integrated 
framework of early intervention palliative care in motor neurone disease as a model 
to progressive neurodegenerative diseases. Poster presented at: 7th European ALS 
Congress; May 22–24, 2009; Turin, Italy35 which was originally adapted from Maddocks 
I, Brew B, Waddy H, Williams I, Palliative Neurology, Cambridge University Press, 2005.98
Abbreviation: ALS, amyotrophic lateral sclerosis.
 
Jo
ur
na
l o
f M
ul
tid
isc
ip
lin
ar
y 
He
al
th
ca
re
 d
ow
nl
oa
de
d 
fro
m
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
13
7.
11
1.
13
.4
 o
n 
26
-J
un
-2
01
7
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
Journal of Multidisciplinary Healthcare 2017:10 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
209
Multidisciplinary care in ALS
in terms of reducing rates of patient hospitalization.30 More-
over, van der Steen et al56 have shown that the cost of special-
ized care provided and coordinated by ALS MDCs was no 
more than the cost of managing ALS through non-specialist 
services. However, the true cost-effectiveness of formal ALS 
care is difficult to determine as patients may engage with 
multiple health care professionals prior to diagnosis.63,64
Connolly et al57 quantified the health and social care costs 
of ALS in Ireland and found that the largest proportion of 
costs (72%) arose in community-based care. Seven percent 
of all costs were attributable to aids and appliances, and only 
21% of costs were attributable to services at the national 
ALS clinic in Ireland. Higher health and social care costs 
were associated with the use of non-invasive ventilation and 
gastrostomy and with shorter survival. Depending on the 
health care system in question, out-of-pocket expenses can 
also be substantial in ALS care.60,61
A review of the economic impact of ALS has also been 
undertaken.65 Standardized to the 2015 USD, Gladman and 
Zinman65 identified significant variation across 12 developed 
health care systems in the annual cost of care for the ALS 
patient. Annual cost of care ranged from $13,667 in Denmark 
to as high as $69,475 in the US. Health care costs associated 
with ALS were also higher than that of other neurological 
conditions. Analysis of the social economic costs of ALS in 
Spain58 found that costs of informal care (ie, non-paid care 
including care provided by family) extended well beyond the 
cost of multidisciplinary care. Furthermore, an economic 
analysis of costs in ALS in Australia59 identified that the 
costs of informal care and support services (eg, aids and 
appliances) exceeded direct health care system costs (ie, 
care facility and health care professional costs). Moreover, 
economic disadvantage through productivity loss is shoul-
dered by family carers, with the Australian economic analysis 
estimating this cost to be AUD 4.4 million.59
Critical issues in multidisciplinary ALS care
Three critical points in ALS patients’ care journey shape their 
health care outcomes and their quality of life. These critical 
points include the timing and delivery of the diagnosis, the 
accessing of MDC care, and the timing of decisions surround-
ing symptom management and end-of-life care.
Timing of the diagnosis
Delays in obtaining a diagnosis in ALS66,67 can result in 
adverse consequences for patients.4,68 Diagnostic delay can 
occur for several reasons, such as inefficient referral pathways 
within health care systems, patients not fully recognizing their 
own symptoms, and a lack of familiarity with ALS among 
non-ALS physicians.63,68,69 Delays have arisen because of late 
referral to specialist investigation, inappropriate referral to 
non-specialist services, and underrecognition of early symp-
toms by health care professionals.63,68,69 Within the secondary-
care sector alone, diagnostic delays can occur when patients 
are referred by non-specialist physicians (ie, physicians 
other than neurologists) to other non-specialist physicians 
before referral onward to neurologists who specialize in 
ALS.69 Indeed, in a US-based study of diagnostic timelines 
in ALS,66 more than half of the participants had received an 
alternative diagnosis before they received a diagnosis of ALS, 
and each patient had seen multiple physicians before their 
diagnosis was confirmed. The average diagnostic timeline 
in ALS has been shown to range between 10 months and 
18 months.16,63,66,67,69 Notwithstanding the complex referral 
trajectory encountered by ALS patients and their families, a 
fast-track system for diagnosing ALS at a specialized ALS 
center reduced diagnostic delays when compared to general 
neurology diagnostic care pathways.69,70 In addition, a “red 
flag” tool has also been developed in the UK to facilitate 
timely referral to specialist services.71
Giving and receiving the diagnosis
The giving and receiving of a terminal diagnosis is a difficult 
and distressing event for health professionals, patients, and 
families. In a recent Australian-based study, neurologists at 
ALS MDCs were judged by patients and family caregivers 
as doing better in disclosing the diagnosis when compared to 
neurologists in non-MDC settings’.13,44,72 Neurologists based 
in MDC settings adhered more to international guidelines16 
on disclosure than did neurologists from non-MDC settings.72 
Of note, the time spent giving the diagnosis to patients was 
significantly longer for the MDC group – an average of 23 
minutes for non-MDC clinicians and twice as long for those 
in MDCs (45 minutes).72 Family members were more likely 
to be present when the diagnosis was disclosed by MDC-
based neurologists. Moreover, coordinated and interprofes-
sional care was more likely to be facilitated by MDC-based 
neurologists.72 
Accessing specialized ALS services
ALS patients have reported difficulty accessing interdisci-
plinary care in community-based settings without assistance 
from specialized MDCs.73 However, patients’ attendance at 
MDCs varies within and between countries. Population-based 
comparative studies between specialized ALS clinics and 
general neurology clinics in Italy30,33  show that between 43% 
and 66% of people with ALS access specialized ALS clinics. 
Approximately 80% of ALS patients in Ireland attend one 
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national ALS clinic32 and an estimated 85% of patients with 
ALS in the Netherlands attend the national ALS Centre.74 In 
Australia, patients attend one of 10 clinics located in six state 
capitals; however, rates of attendance are undocumented. A 
survey of ALS patients in the US revealed that 78% of respon-
dents attended a specialized ALS MDC,75,76 whereas in the 
UK it is estimated that 70% of ALS patients access MDCs.77
Stephens et al’s study of multidisciplinary ALS clinic 
use in the US76 reported patient perspectives on the benefits 
and barriers to attending specialized ALS clinics. Access 
to integrated care and the potential to engage in research, 
including clinical trials, were valued by patients. However, 
the long duration of MDC visits and patients’ reluctance to 
travel long distances to MDCs also limited the attendance 
for some patients. The European Federation of Neurological 
Societies (EFNS) guidelines recommend that more frequent 
reviews for patients at MDCs in the months following diag-
nosis or in the later stages of disease may be needed, with 
less frequent review if the disease is progressing slowly for 
patients.16 In the US, 3-monthly visits by ALS patients to 
large MDCs are common.62 Nevertheless, for a proportion 
of patients, an MDC visit may be a single occurrence only. 
Few large-scale studies have captured the journey that 
patients and their families travel from symptom onset to 
specialized multidisciplinary ALS care. Galvin et al63 con-
ducted a retrospective exploratory study that tracked ALS 
patients’ paths to a specialized ALS clinic. The average 
time from symptom onset to attendance at the MDC was 19 
months. The first point of contact for ALS patients in health 
care services was invariably a general practitioner. Even so, 
patients also had multiple consultations with other services 
in primary and secondary care (eg, accident and emergency, 
other neurology services, and individual allied health care 
professionals) before they received a diagnosis or attended 
the clinic. Patients’ consultations with disciplines prior to 
diagnosis or attendance at the MDC clinic tended not to be 
coordinated between disciplines. However, most MDCs are 
located in metropolitan regions and in large tertiary hospitals 
or centers and may not be accessible to some patients and 
their family. Moreover, health care organization funding may 
limit the availability of services to patients living outside their 
catchment area or geographical boundary. Patients who live 
a long distance from an MDC may be at a disadvantage in 
the latter stages of the disease, particularly when fatigue and 
mobility restrictions increase for them.76 
The use of tele-health has the potential to offset some of 
the logistical difficulties associated with accessing special-
ized ALS clinics. Where patients are unable to physically 
access the MDC, tele-health can enable the MDC team to 
interface with patients and their family in the home environ-
ment.77,78 In addition, tele-health has the potential for local 
and community-based services to engage with the MDC in 
real time and to partner the MDC in the decision-making 
process.77,78 In the case of respiratory care, the benefits of 
tele-health for ALS patients have been reported.79,80 The set-
ting and monitoring of invasive81 and non-invasive ventila-
tion82 where the parameters for clinical assessment can be 
downloaded from a remote location have strong application 
in a tele-health model of care. Tele-health can be provided 
to ALS patients in conjunction with or as follow-up to 
face-to-face visits with patients.80 Continuity of care and 
of symptom management are specific advantages of tele-
health for ALS patients,78 and both patients and clinicians in 
ALS care have been shown to be receptive to tele-health80,81 
One study showed that tele-health for ALS care impacted 
positively on health care utilization, patient survival, and 
patient functional status.82 Nurse-led tele-health may also 
be beneficial if initiated in the later stages of the disease.79 
Further investigation into the application of tele-health in 
multidisciplinary rehabilitation and palliative care services 
for ALS patients and their families is required.
Timing of decisions for symptom management and 
end-of-life care
Patients (and families) are often required to make decisions 
for symptom management and quality of life as the disease 
progresses.83–85 Decisions are made with multiple health pro-
fessionals and require cross-sector coordination. Decisions 
for life-extending or symptomatic measures (eg, gastrostomy, 
invasive ventilation and non-invasive ventilation), as well 
as end-of-life care, are complex.16,17 Successful outcomes 
can depend upon the timing of interventions. Patients are 
encouraged to consider their options and make choices about 
care in a timeframe that enables successful outcomes for 
both patients and their family caregivers. The consequences 
of avoiding decision making, for example, for nutrition/
hydration or respiratory distress, can impact the patient’s 
health and quality of life. However, some patients may also 
feel conflicted by having to make decisions about care.86,87 
Patients may not feel ready for procedures or equipment that 
signal further deterioration in their condition and that which 
would increase their dependence on family members. Life-
extending measures may also conflict with patients’ and fam-
ily caregivers’ long-held values pertaining to end-of-life care. 
The ALS MDC can offer patients and their family 
caregivers a supportive setting when discussing treatment 
decisions.86,87 A model to guide decision making in ALS that 
incorporates patients and their carers in the decision-making 
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processes of care has been developed from the MDC set-
ting.22,38 This model facilitates shared decision making with 
patients and their carers and situates patients and their carers 
within the multidisciplinary network of care. Allowing suf-
ficient time and space for patients and their carers to digest 
information about care, deliberate on the options available 
to them, and make decisions about how they would like to 
engage with multidisciplinary care are key components of 
inclusive decision making in multidisciplinary ALS care.22 
The ALS MDC setting can be a suitable forum for a mul-
tidisciplinary team to collectively engage with patients and 
their family in shared decision making pertaining to symptom 
management and quality-of-life choices.87 
Developments in multidisciplinary 
ALS care
The evolving multidisciplinary ALS care team
As models of care evolve to keep pace with the new under-
standing of this complex disorder, the multidisciplinary ALS 
care team has expanded accordingly.10,16,17,42,88 Recent addi-
tions to the multidisciplinary ALS care team have included 
neuropsychologists, genetic counselors, and case managers. 
A frontotemporal syndrome occurs in a substantial proportion 
of ALS patients, a subgroup of whom present with fronto-
temporal dementia.89 Expert consensus is that care provi-
sion in ALS should include interventions directed toward 
the management of cognitive and behavioral impairment in 
ALS, including educational and support services for family 
carers on how best to support and care for ALS patients who 
have cognitive or behavioral impairment.10,16 In this context, 
neuropsychologists make an important contribution to the 
care of ALS patients and their caregivers. 
The identification of multiple novel genes in ALS and 
the newly recognized link between ALS and frontotemporal 
dementia have resulted in the need to incorporate genetic 
counseling into multidisciplinary ALS care.16,90,91. However, 
ALS patients have reported difficulty accessing genetic test-
ing.92 Indeed, studies have yet to estimate the proportion of the 
ALS population that engage with genetic testing and genetic 
counseling. Genetic counseling in ALS may pose significant 
challenges to patients, family, and health professionals, in the 
context of the ethical, legal, and psychological dimension 
surrounding disclosure, and the impact the disclosure can 
have on the wider family.91 Nonetheless, ALS patients have 
reported high levels of interest in genetic testing.92
The role of case management in ALS, in which desig-
nated professionals work collaboratively with patients and 
their families, guiding and supporting them through the 
different phases of care, has been examined.42,88 Initially, 
a Dutch randomized control study on case management in 
ALS88 showed that case management conferred no benefit 
to patient health-related quality of life or to caregiver strain 
when compared to normal care. However, a qualitative inves-
tigation of patients’ and their caregivers’ perceptions of the 
same service42 identified that ALS patients and their families 
were receptive to case management and that they valued the 
additional emotional support available to them from a case 
manager. Patients’ and caregivers’ own coping styles and their 
satisfaction or dissatisfaction with usual care influenced how 
receptive they were to case management.42
Benefits and challenges to health professionals 
in delivering coordinated and interprofessional 
ALS care
Alongside the benefits that patients and their family encoun-
ter in multidisciplinary ALS care are advantages to health 
care professionals who work within the MDCs. Health 
professionals gain experience and expertise in ALS care,93 
learning from patients and family caregivers when supported 
in a clinical environment dedicated to ALS care. Although 
patient satisfaction with MDC services is in general high,62 
the provision of multidisciplinary-based care to people 
with ALS and their families can have a significant impact 
on health care professionals who render and coordinate the 
care. Health professionals in ALS care can experience vary-
ing degrees of stress related to their clinical work,94 and the 
emotional burden encountered by health care professionals 
caring for people with ALS can be severe.55 Feelings of 
stress and anxiety can arise for physicians while deliver-
ing the diagnosis and prognosis,72 whereas withdrawal of 
treatments can pose ethical and psychological dilemmas for 
health care professionals who provide end-of-life care.95,96 In 
an Australian-based study,72 70% of neurologists surveyed 
found communicating the diagnosis of ALS “very to some-
what difficult,” whereas 43% of them found responding to 
patients’ and family members’ reaction to the disclosure “very 
to somewhat difficult.” Sixty-five percent of neurologists 
experienced “high to moderate” stress and anxiety during 
the disclosure. Physicians reported the challenges surround-
ing the need to be honest without taking away hope, dealing 
with the patient’s emotional reaction to the diagnosis, and 
judging the optimal amount of time to deliver the diagnosis. 
The reasons for experiencing these difficulties included the 
lack of effective treatments in ALS, fear of causing distress 
to patients, and fear of not having all the answers for patients. 
Support and education systems need to be developed that 
help health care professionals to manage the emotional and 
moral distress that they encounter in ALS practice.97 Connolly 
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et al55 called for a recognition of the emotional burden that 
health care professionals encounter when caring for people 
with ALS, “with structures and procedures developed to 
address compassion, fatigue, and the moral and ethical chal-
lenges related to providing end-of-life care” (p. 435). Support 
from health care organizations is required to ensure that health 
professionals in multidisciplinary ALS care are financially 
and emotionally supported in their role as service providers.87
Conclusion
Specialized multidisciplinary care is more than a means 
of delivering appropriate symptom management to ALS 
patients. This review has identified that coordinated and 
interprofessional care that meets the expectations of ALS 
patients and their families is a combination of multiple facets 
of care. These include care underpinned by an increasing 
evidence base; service providers applying a patient- if not 
family-centric approach to care; strong inter-service com-
munication; and an interprofessional team resourced and 
funded to provide expert care to patients and their family 
caregivers.
MDC-based care in ALS offers benefits and challenges 
to patients, carers, and health professionals. Importantly, the 
evidence in ALS care has been fueled by research undertaken 
and coordinated by MDCs.23,29,32 The links between interpro-
fessional practice and clinical research are strengthened when 
frontline clinicians, patients, and carers are able to contribute 
to our understanding of how multidisciplinary ALS care 
improves patient care and quality of life.
Although MDCs offer an optimal model of coordinated 
interprofessional care, the transition of care between care 
settings remains a concern. Strategies toward standardizing 
care delivery for patients and carers may help to reduce the 
wide-ranging experiences from the very good to the not so 
good. The development of best practice guidelines and of 
protocols to improve inter-service communication skills 
among health care professionals may alleviate the emotional 
burden of service providers and the distress that patients 
and their family encounter when confronted with poorly 
coordinated care. 
Finally, patients’ attendance rates at specialized ALS 
MDCs show that a significant portion of ALS patients are 
not able, or choose not, to access MDC care. Stronger links 
between specialized ALS MDC services, general neurology, 
and primary care services could improve the quality of care 
for patients being managed in their own community and 
increase the expertise of practitioners outside the current 
MDC network. An improved understanding among the wider 
health care community of how MDC teams deliver care will 
assist the development of clinical pathways that connect 
MDC and non-MDC services. A network that is accessible 
to all clinical services caring for ALS patients will improve 
patient care, service transition, and health care professionals’ 
understanding of ALS.
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